Giuseppe Colantuoni

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

Lucia Del Mastro, Sabino De Placido, Paolo Bruzzi et al. · The Lancet · 2015 · 201 citations

Medicine, Oncology, Pharmacology +15

Sorafenib and Sunitinib in the Treatment of Advanced Non-Small Cell Lung Cancer

Cesare Gridelli, Paolo Maione, Filomena Del Gaizo et al. · The Oncologist · 2007 · 118 citations

Medicine, Oncology, Pharmacology +14

Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

Fortunato Ciardiello, Teresa Troiani, Francesca Caputo et al. · British Journal of Cancer · 2006 · 82 citations · Full text

Medicine, Oncology, Pharmacology +17

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial

Francesco Perrone, Francesco Nuzzo, Francesca Di Rella et al. · Annals of Oncology · 2014 · 68 citations · Full text

Medicine, Geriatric Medicine, Oncology +12

Etoposideversus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial

Riccardo Rosso, Franco Salvati, Andrea Ardizzoni et al. · Cancer · 1990 · 53 citations

Medicine, Oncology, Pharmacology +10